Organon (OGN) Assets Average (2021 - 2026)
Organon (OGN) posted quarterly Assets Average of $13.1 billion for Q2 2026, down 1.81% year-over-year from $13.3 billion in Q2 2025, and up 1.2% on a QoQ basis from $12.9 billion in Q1 2026.
Organon (OGN) Assets Average (2021 - 2026) Analysis & Trends
Organon has reported Assets Average for 6 years, with the latest figure at $13.1 billion in Q2 2026.
- Assets Average for Q2 2026 came in at $13.1 billion, down 1.81% year-over-year; the trailing twelve-month figure through Jun 2026 was $13.1 billion (down 1.81% YoY), and the FY2025 annual result was $13.0 billion, up 3.22% from the prior year.
- Assets Average rose to $13.1 billion in Q2 2026, from $12.9 billion in the prior quarter.
- Over five years, Assets Average peaked at $13.5 billion in Q3 2025 and troughed at $10.5 billion in Q3 2022.
- A 5-year average of $12.0 billion and a median of $12.0 billion in 2024 frame the typical range for Assets Average.
- The widest annual swing landed in 2022, when Assets Average dropped 5.36%; it then increased 13.26% in 2024.
- A 5-year view of Assets Average shows it stood at $10.7 billion in 2022, then increased by 7.84% to $11.5 billion in 2023, then rose by 12.06% to $12.9 billion in 2024, then increased by 2.19% to $13.2 billion in 2025, then fell by 0.93% to $13.1 billion in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $13.1 billion in Q2 2026, $12.9 billion in Q1 2026, and $13.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 114.92 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 94.07 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 52.82 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 204.57 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 83.80 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 13.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.09 Bn |
| Mar 31, 2026 | 12.93 Bn |
| Dec 31, 2025 | 13.21 Bn |
| Sep 30, 2025 | 13.53 Bn |
| Jun 30, 2025 | 13.33 Bn |
| Mar 31, 2025 | 13.13 Bn |
| Dec 31, 2024 | 12.93 Bn |
| Sep 30, 2024 | 12.45 Bn |
| Jun 30, 2024 | 12.02 Bn |
| Mar 31, 2024 | 11.97 Bn |
| Dec 31, 2023 | 11.54 Bn |
| Sep 30, 2023 | 11.00 Bn |
| Jun 30, 2023 | 10.87 Bn |
| Mar 31, 2023 | 10.86 Bn |
| Dec 31, 2022 | 10.70 Bn |
| Sep 30, 2022 | 10.53 Bn |
| Jun 30, 2022 | 10.61 Bn |
| Mar 31, 2022 | 10.64 Bn |
| Dec 31, 2021 | 11.01 Bn |
| Sep 30, 2021 | 11.12 Bn |